Molecular Devices Launches Dual-Camera ImageXpress® HCS.ai Advanced Duo High-Content Screening System to Help Drug Discovery Teams Reach Decisions Faster
New high-content screening platform connects image acquisition, AI-enabled analysis, and screening analytics to eliminate workflow handoffs and accelerate the path from sample to decision SAN JOSE, Calif., Oct. 27, 2026 /PRNewswire-PRWeb/ -- Molecular Devices, a Danaher company and a...